Gujarat, India

Zubeda Begum

USPTO Granted Patents = 1 

Average Co-Inventor Count = 13.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Zubeda Begum: Innovator in Asymmetric Synthesis

Introduction

Zubeda Begum is a prominent inventor based in Gujarat, India. She has made significant contributions to the field of chemistry, particularly in the area of asymmetric synthesis. Her innovative work has led to the development of a unique method for synthesizing azaspiro compounds, which has important implications in pharmaceuticals.

Latest Patents

Zubeda Begum holds a patent for the "Asymmetric synthesis of Azaspiro compounds." This invention relates to an improved method for synthesizing azaspiro or diazaspiro compounds and their pharmaceutically acceptable salts and derivatives. The process involves the formation of intermediate compounds through a highly diastereoselective and enantio-enriched approach. By utilizing a cyclobutane carboxylate anion in conjunction with a Davis-Ellman's imine, she has achieved selective formation of the desired azaspiro or diazaspiro compounds.

Career Highlights

Zubeda Begum is currently employed at Piramal Pharma Limited, where she continues to advance her research in pharmaceutical chemistry. Her work has garnered attention for its innovative approach and potential applications in drug development. With a patent portfolio that includes 1 patent, she is recognized as a valuable contributor to her field.

Collaborations

Zubeda has collaborated with notable colleagues, including Rajender Reddy Leleti and Yogesh Waman. These partnerships have enhanced her research efforts and contributed to the successful development of her patented technologies.

Conclusion

Zubeda Begum's contributions to asymmetric synthesis exemplify the impact of innovative thinking in the pharmaceutical industry. Her work not only advances scientific knowledge but also holds promise for future medical applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…